Thyroid Dysfunction in Patients With Nephrotic Syndrome
Launched by MERNA MAKRAM · Mar 25, 2020
Trial Information
Current as of June 20, 2025
Unknown status
Keywords
ClinConnect Summary
Nephrotic syndrome (NS) is one of the most popular glomerular diseases all over the world It result in loss of various macromolecules which exist in the plasma and bound to plasma proteins. They are carried away and lost in the urine due to increase glomerular membrane permeability.The abnormalities arising as a result of persistence of generalized edema , substantial heavy proteinuria \>3,5 gm/24 h 3, hypoalbuminemia\<30 g/L and hyperlipidemia Also, nephrotic syndrome may associated with thromboembolism and increase risk of infection, vitamin D deficiency, Iron deficiency and endocrine abn...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Nephrotic syndrome defined by the following:
- • 1. Generalized edema
- • 2. Urine protein excretion \> 3,5 g/24 hours
- • 3. Urine protein to creatinine ratio \> 3,500mg/g
- • 4. Serum albumin level less than 30 g/L
- Exclusion Criteria:
- • - 1) Patients \< 18 years old 2) Patients who have Thyroid diseases, current or past history of thyroid hormone or antithyroid drug intake.
- • 3) Patients who have diabetes mellitus or autoimmune diseases as systemic lupus erythematosus and RA 4) Medications known to affect thyroid function. 5) Patients with liver cirrhosis and chronic liver disease as augmentin
About Merna Makram
Merna Makram is a dedicated clinical trial sponsor focused on advancing medical research and innovation. With a commitment to improving patient outcomes, the organization specializes in the development and management of clinical trials across various therapeutic areas. Leveraging a robust network of clinical sites and a team of experienced professionals, Merna Makram strives to ensure the highest standards of compliance and ethical conduct in research. Their mission is to facilitate groundbreaking studies that contribute to the understanding and treatment of diseases, ultimately enhancing healthcare solutions for communities worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials